Drug Profile

Universal influenza vaccine - Onconetix/University of Oxford

Alternative Names: BWV-101; BWV-102; Universal flu vaccine - Onconetix/University of Oxford

Latest Information Update: 28 Mar 2025

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator University of Oxford
Developer Instituto Butanan; Onconetix; University of Oxford
Class Influenza virus vaccines
Mechanism of Action Immunostimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Preclinical Influenza virus infections

Most Recent Events

28 Mar 2025 No recent reports of development identified for preclinical development in Influenza-virus-infections(Prevention) in United Kingdom (IM, Injection)
18 Dec 2023 Proteomedix has merged with Blue Water Biotech to form Onconetix
24 Apr 2023 Blue Water Vaccines is now called Blue Water Biotech

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com